+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 9Months - 21Years
All Genders
ID05219110

Early High-Volume IV Fluids to Protect Kidneys in Children With Shiga Toxin-Producing E. Coli Infection A Randomized Multinational Trial

Led by University of Calgary · Updated on 2026-05-18

1040

Participants Needed

26

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating whether early, high-volume intravenous fluid administration hyperhydration can help reduce or prevent complications in children and adolescents infected with shiga toxin-producing Escherichia coli STEC, compared to traditional conservative fluid management. The study focuses on hemolytic uremic syndrome HUS, a serious complication of STEC infection that can cause acute kidney injury and other life-threatening effects. Despite low mortality, many affected children face long-term health issues, and previous trials have not proven effective treatments since 1999. Participants are randomly assigned to one of two groups. The hyperhydration group receives intravenous fluids at 200% of maintenance for 24 hours, with adjustments based on hematocrit levels and weight gain, alongside allowed oral fluids. The conservative group follows current local practices, with fluid management decided by the clinical care team and admission based on specific lab evidence. This study also establishes a biorepository to explore biomarkers and potential treatments. During the study, children are admitted for monitoring and receive fluid therapy according to their assigned group. Researchers assess kidney outcomes and serious complications over 30 days, focusing on major adverse kidney events including death, need for renal replacement therapy, or sustained kidney function loss. Safety and kidney health are closely monitored, with outcomes informing future care. The total participation time includes the initial treatment period and 30-day follow-up for outcome evaluation.

CONDITIONS

Brief Title

Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection

Research Team

S

Study Manager

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here